Tower Research Capital LLC (Trc) Hepion Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.31 - $1.06 $6,734 - $23,028	-21,725 Reduced 67.28%	10,564 $8,000
Q4 2022 Feb 10, 2023	BUY	$0.27 - $11.9 $3,327 - $146,643	12,323 Added 61.72%	32,289 $10,000
Q3 2022 Nov 10, 2022	BUY	$0.51 - $10.4 $4,242 - $86,507	8,318 Added 71.41%	19,966 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.57 - $1.22 $5,567 - $11,916	9,768 Added 519.57%	11,648 $7,000
Q1 2022 May 12, 2022	BUY	$0.93 - $1.29 $1,748 - $2,425	1,880 New	1,880 $2,000
Q3 2021 Nov 15, 2021	SELL	$1.39 - $2.1 $4,751 - $7,177	-3,418 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.56 - $2.26 $34,148 - $49,471	-21,890 Reduced 86.49%	3,418 $7,000
Q1 2021 May 17, 2021	BUY	$1.77 - $2.98 $44,795 - $75,417	25,308 New	25,308 $46,000
Q4 2020 Feb 16, 2021	SELL	$1.58 - $3.64 $7,140 - $16,449	-4,519 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.84 - $4.59 $12,833 - $20,742	4,519 New	4,519 $14,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $35.1M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.